Cns Pharmaceuticals Inc (CNSP) Financials

$5.73

$-0.16 (-2.66%)

As on 04-Sep-2026 16:00EDT

Market cap

$8 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.00	--	0.00	0.00	0.01	0.01
Gross Profit	0.00	--	0.00	0.00	-0.01	-0.01
Operating Expenses	16.92	15.99	14.90	18.86	14.92	14.47
Operating Profit (EBIT)	-16.91	-15.99	-14.90	-18.87	-14.93	-14.49
Other Income	--	--	--	--	--	--
Profit before Tax	-16.70	-15.85	-14.86	-18.85	-15.27	-14.50
Provision for Tax	--	--	--	0.00	0.01	0.01
Profit after Tax (Net Income)	-16.70	-15.85	-14.86	-18.85	-15.27	-14.50
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-14.04

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	18.20	4.52	6.18	-4.43	8.13	6.62
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	4.09	1.91
Current Liabilities	3.74	4.10	2.52	6.13	4.92	2.14
Total Liabilities	25.68	8.62	8.70	1.70	13.05	8.76

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.02	0.52	0.04	0.11	0.49	1.28
Current Assets	21.92	8.10	8.66	1.59	12.56	7.48
Total Assets	43.86	8.62	8.70	1.70	13.05	8.76
Total Debt*	--	0.33	0.33	0.30	0.41	0.39
Net Current Assets	--	4.00	6.13	-4.54	7.64	5.34

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-13.81	-17.11	-14.14	-10.56	-13.54
Cash Flow from Investing Activities	--	-0.02	0.00	0.00	0.00	-0.01
Cash from Financing Activities	--	14.57	23.03	4.64	15.61	4.51
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-279.21	-1,253.10	-854.64	-196.42	-135.49
ROE (%)	-146.98	-296.30	-1,703.39	-1,018.78	-207.04	-140.94
ROA (%)	-55.90	-182.99	-285.68	-255.54	-140.06	-117.80
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-8.04	-6.70	21.21	-23.39	-5.39	-53.22
Net Profit Growth (%)	-8.03	-6.68	21.18	-23.42	-5.37	-53.26
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.47	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.40	0.43	0.41	0.01	0.63	0.32
Close Price ($)	4.78	5.25	72.24	38,100.00	72,000.00	632,160.00
High Price ($)	12.36	114.00	39,000.00	132,000.00	1,242,000.00	4,014,000.00
Low Price ($)	1.90	4.93	57.30	18,315.00	61,500.00	623,160.00
Market Cap ($ Cr)	8.37	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.07	0.05	-0.07	0.05	0.06
Short term debt to equity ratio	--	0.07	0.05	-0.07	0.05	0.06
Current Ratio	5.86	1.98	3.43	0.26	2.55	3.50
Quick Ratio	5.86	--	--	--	--	--
Interest Coverage	-1,116.16	-1,039.75	-920.76	-1,364.54	-2,172.64	-1,560.14

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	443,604.30	420,296.46	80,853.40	34,501.08
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.